Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

AstraZeneca drug acquired in Alexion deal succeeds in autoimmune disease trial

Summary by biopharmadive.com
The pharmaceutical giant sees the drug, gefurulimab, as a more convenient, self-administered alternative to the infused medicines it currently sells for  myasthenia gravis.

2 Articles

biopharmadive.combiopharmadive.com
Center

AstraZeneca drug acquired in Alexion deal succeeds in autoimmune disease trial

The pharmaceutical giant sees the drug, gefurulimab, as a more convenient, self-administered alternative to the infused medicines it currently sells for  myasthenia gravis.

Read Full Article
leseco.maleseco.ma

Rare Diseases: Fm6ss and Astrazeneca Unite to Create Centres of Excellence

The Mohammed VI Foundation of Science and Health and the AstraZeneca Laboratory have formalized a partnership to create centres of excellence dedicated to rare diseases. The post Rare Diseases: FM6SS and AstraZeneca unite to create centres of excellence appeared first on LesEco.ma.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

biopharmadive.com broke the news in on Thursday, July 24, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Medical icon

Medical

Morocco icon

Morocco

You have read 1 out of your 5 free daily articles.

News
For You
SearchBlindspotLocal